Clinical Trials

PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and...

Introduction Successful clinical trials rely on effective patient recruitment and retention. However, a 2019 report indicates that the industry continues to struggle meeting these objectives. The study found that about 80 percent of clinical trials don’t meet patient enrollment deadlines,...

CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak. With...

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug candidate that combines Zydus’ IL-2 with XOMA’s novel anti-IL-2 monoclonal antibody. As part of the...

Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS). ISO 27001:2013 is a standard set by the International Organization for Standardization (ISO), the independent, non-governmental international organization of national...

Introduction: Patients, clinical trial sponsors and institutions are starting to benefit from increased transparency commitments and significant investments in trial data disclosure. To make an ever-broader scope of trial data public, leading pharmaceutical organizations have been refining their processes and...

Bellerophon Therapeutics, Inc , a clinical-stage biotherapeutics company, announced the successful completion of its End-of-Phase 2 Meetings with the U.S. FDA for INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF). The Company, in consultation with the...